| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lipocine Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 176K | $46.7K | $0.27 | Dec 7, 2021 | Direct |
| Clene Inc. | Chief Financial Officer | Stock Options (Right to buy) | 600K | Jun 7, 2024 | Direct | ||
| Clene Inc. | Chief Financial Officer | Stock Options (Right to buy) | 10K | Aug 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CLNN | Clene Inc. | Aug 16, 2024 | 1 | $0 | 4 | Aug 19, 2024 | Chief Financial Officer |
| CLNN | Clene Inc. | Jun 7, 2024 | 2 | $0 | 4 | Jun 11, 2024 | Chief Financial Officer |
| CLNN | Clene Inc. | Jun 29, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Chief Financial Officer |
| CLNN | Clene Inc. | Feb 17, 2023 | 1 | $0 | 4 | Feb 21, 2023 | Chief Financial Officer |
| CLNN | Clene Inc. | Nov 4, 2022 | 1 | $0 | 4 | Nov 7, 2022 | Chief Financial Officer |
| CLNN | Clene Inc. | Feb 1, 2022 | 0 | $0 | 3 | Feb 3, 2022 | Chief Financial Officer |
| CLNN | Clene Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Financial Officer |
| LPCN | Lipocine Inc. | Dec 7, 2021 | 1 | $197K | 4 | Dec 8, 2021 | Chief Financial Officer |